FDA Adverse Event Malfunction Summary report: N

PROGRAMMING SOFTWARE

MDR report key: 14624627 · Received June 7, 2022

Report

Report Number
1644487-2022-00670
Event Type
Malfunction
Date Received
June 7, 2022
Date of Event
May 13, 2022
Report Date
January 10, 2023
Manufacturer
LIVANOVA USA, INC.
Product Code
LYJ
PMA / PMN Number
P970003
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

LIVANOVA USA, INC. SUBMITS THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION, BASED ON INFORMATION THAT LIVANOVA HAS OBTAINED, BUT MAY NOT HAVE BEEN ABLE TO INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION, OR A CONCLUSION BY FDA OR ANYONE ELSE, THAT THE DEVICE, LIVANOVA, OR LIVANOVA'S EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY ;DEFECTS¿ OR ;MALFUNCTIONS¿. THESE WORDS ARE INCORPORATED INTO THE FDA 3500A MEDWATCH FORM BY THE FDA, AND LIVANOVA OBJECTS TO THEIR USE.

Description of Event or Problem · 0

FOLLOWING AN INCREASE IN SEIZURES, THE PATIENT¿S DEVICE WAS CHECKED AND IT WAS SEEN THAT THE PARAMETERS WERE RESET WITH AN OUTPUT CURRENT AT 0MA. IT WAS NOTED THAT THE PATIENT DID NOT HAVE AN MRI TO TURN DEVICE OFF. THE PATIENT HAS A MODEL 102 DEVICE WHICH BASED ON THE DESIGN OF THE DEVICE CAN RESET SETTINGS UPON INTERRUPTED SYSTEM DIAGNOSTIC TESTING. IN THIS CASE, IT IS MOST LIKELY THAT THE CAUSE OF THE DEVICE SETTING TO 0MA IS DUE TO A PREVIOUS SYSTEM DIAGNOSTIC TEST BEING PERFORMED, BEING INTERRUPTED AND UNINTENTIONALLY CHANGING SETTINGS TO INTENDED VALUES. NO ADDITIONAL RELEVANT INFORMATION HAS BEEN RECEIVED TO DATE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1320377 PROGRAMMING SOFTWARE PROGRAMMING SOFTWARE LYJ LIVANOVA USA, INC. MODEL 250

Patients

Seq Age Sex Outcome Treatment
1 Unknown